Evogene loss widens to USD 7.66 million in six months ended June 30, 2026; revenue drops 76% to USD 681,000
Bitget2026/09/28 20:11- Evogene posted a loss of USD 7.66 million for the six months ended June 30, 2026, little changed year over year.
- Revenue fell 76% to USD 681,000 from the year-earlier period.
- Operating loss widened 11% to USD 5.39 million.
- Loss before taxes on income widened 75% to USD 7.17 million, while net financing results swung to a loss of USD 1.74 million.
- Cash and cash equivalents declined to USD 9.32 million at June 30, 2026 from USD 12.96 million at Dec. 31, 2025.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Is AI an engine or a killer? Morgan Stanley provides answers with data: productivity soars, but nearly 90% of the benefits are taken by 12 industries
Morgan Stanley stated that the productivity dividends from AI are concentrated in 12 highly exposed industries, with growth rates reaching twice the twenty-year average. For the first time, signs of job replacement have emerged.
Production Increase Falls Short, Layoffs First! Boeing (BA.US) Cuts 5% of Commercial Airplane Jobs, Delays 737 Monthly Production Target of 47 Aircraft to 2027
Stephanie Pope, head of Boeing's commercial airplanes division, informed employees in an internal memo on Monday that due to obstacles in increasing aircraft production, the division plans to cut 5% of its workforce.
Crypto prices
More
